DEEPTI BEHL, M.D.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    AZ
    Topic:
    Lung cancer
    Date added:
    03/19/2024
    Date updated:
    03/19/2024
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Novartis
    Topic:
    Lung cancer
    Date added:
    03/19/2024
    Date updated:
    03/19/2024
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    boehringer
    Topic:
    Lung cancer
    Date added:
    03/19/2024
    Date updated:
    03/19/2024
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    BMS
    Topic:
    Lung/melanoma
    Date added:
    03/19/2024
    Date updated:
    03/19/2024
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    janssen
    Topic:
    Lung cancer
    Date added:
    03/19/2024
    Date updated:
    03/19/2024
    Relationship end date:
    03/31/2024
Return to 4th Binaytara Precision Oncology Summit: Current Standards and Emerging Therapies